Fielmann AG
Fielmann AG (FLMNY) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
flmny · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Medical - Instruments & Supplies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Fielmann AGYou FLMNY | $4.3B | N/A | — | — |
 AddLife AB (publ) ADDLF | $4.9B | 84.26x | +104.1% | $4.60 |
 Asahi Intecc Co., Ltd. AHICF | $6.0B | 49.62x | +20.2% | $46.92 |
 ALK-Abelló A/S AKBLF | $6.3B | 42.58x | +3.1% | $5.39 |
 Clicks Group Limited CLCGY | $3.3B | 28.13x | -31.9% | $26.57 |
 COSMOS Pharmaceutical Corporation CSMYF | $3.3B | 16.92x | -59.0% | $390.86 |
 Carl Zeiss Meditec AG CZMWF | $2.7B | 26.20x | -36.5% | $1.61 |
Industry Average 6 peers with valid PE | — | 41.29x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Fielmann AG (FLMNY) measures how much investors pay for each dollar of the company's trailing earnings. FLMNY's current PE ratio of N/A is calculated by dividing its stock price of $10.13 by its TTM earnings per share of —.
Frequently asked questions
FLMNY pe ratio · 6 questionsFLMNY's current PE ratio is N/A as of 2026-06-09, based on a stock price of $10.13 and TTM EPS of —. Data sourced from Financial Modeling Prep via FLMNY's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Fielmann AG SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09